Heat-shock protein expression in cisplatin-sensitive and -resistant human tumor cells

International Journal of Cancer

Volumn 67, Issue 6, 1996, Pages 800-807

  Hettinga, Judith V E ^a   Lemstra, Willy ^a   Meijer, Coby ^a   Los, Gerrit ^b   De Vries, Elisabeth G E ^b   Konings, Antonius W T ^a   Kampinga, Harm H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; HEAT SHOCK PROTEIN; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CISPLATIN; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; HEAT-SHOCK PROTEINS; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PHOSPHORYLATION; TUMOR CELLS, CULTURED;

EID: 0029926499     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960917)67:6<800::AID-IJC8>3.0.CO;2-V     Document Type: Article

References (37)

1. AGGARWAL, S.K., Fine structural studies using platinum coordination complexes. J. clin. Hematol. Oncol., 7, 760-796 (1977).
2. ARRIGO, A.-P. and LANDRY, J., Expression and function of the low-molecular-weight heat-shock proteins. In: R.I. Morimoto, A. Tissieres and C. Georgopoulos (eds.), Biology of heat-shock proteins and molecular chaperones, pp. 335-376, CSH Press, Cold Spring Harbor, NY (1994).
3. BIELKA, H., HOINKIS, G., OESTERREICH, S., STAHL, J. and BENNDORF, R., Induction of the small stress protein, hsp25, in Ehrlich ascites carcinoma cells by anticancer drugs. FEBS Lett., 343, 165-167 (1994).
4. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
5. CHRISTEN, R.D., ISONISHI, S., JONES, J.A., JEKUNEN, A.P., HOM, D.K., KRONING, R., GATELY, D.P., THIEBAUT, F.B., Los, G. and HOWELL, S.B., Signaling and drug sensitivity. Cancer Metast. Rev., 13, 175-189 (1994).
6. CHRISTEN, R.D., JEKUNEN, A.P., JONES, J.A., THIEBAUT, F., SHALINSKY, D.R. and HOWELL, S.B., In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacological alteration of microtubules. J. clin. Invest., 92, 431-440 (1993).
7. CIOCCA, D.R., CLARK, G.M., TANDON, A.K., FUQUA, S.A., WELCH, W.J. and MCGUIRE, W.L., Heat shock protein hsp70 in patients with axillary lymph-node-negative breast cancer: prognostic implications. J. nat. Cancer Inst., 85, 570-574 (1993).
8. CIOCCA, D.R., FUQUA, S.A.W., LOCK-LIM, S., TOFT, D.O., WELCH, W.J. and MCGUIRE, W.L., Response of human breast cancer cells to heat shock and chemotherapeutic drugs, Cancer Res., 52, 3648-3654 (1992).
9. ELLEDGE, R.M., CLARK, G.M., FUOUA, S.A., YU, Y.-Y. and ALLRED, D.C., p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer. Cancer Res., 54, 3752-3757 (1994).
10. HETTINGA, J.V.E., LEMSTRA, W., KONINGS, A.W.T. and KAMPINGA, H.H., Cisplatin sensitivity and thermochemosensitisation in thermotolerant cDDP-sensitive and -resistant cell lines. Brit. J. Cancer, 71, 498-504 (1995).
11. HOSPERS, G.A.P., MULDER, N.H., DE JONG, B., DE LEY, L., UGES, D.R.A., FICHTINGER-SCHEPMAN, A.M.J., SCHEPER, R.J. and DE VRIES, E.G.E., Characterization of a human small cell lung carcinoma cell tine with acquired cisplatin resistance in vitro. Cancer Res., 48, 6803-6807 (1988).
12. r 27,000 heat shock protein. Cancer Res., 51, 5245-5252 (1991).
13. HURLIMANN, J., GEBHARD, S. and GOMEZ, F., Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomas. Histopathology, 23, 239-248 (1993).
14. KAMPINGA, H.H., Thermotolerance in mammalian cells: protein denaturation and aggregation, and stress proteins. J. Cell Sci., 104, 11-17 (1993).
15. KIMURA, E., ENNS, R.E., ALCARAZ, J.E., ARBOLEDA, J., SLAMON, D.J. and HOWELL, S.B., Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60. J. clin. Oncol., 11, 891-898 (1993a).
16. KIMURA, E., ENNS, R.E., THIEBAUT, F. and HOWELL, S.B., Regulation of HSP60 mRNA expression in a human ovarian carcinoma cell line. Cancer Chemother. Pharmacol., 32, 279-285 (1993b).
17. KNAUF, U., BIELKA, H. and GAESTEL, M., Over-expression of the small heat-shock protein, hsp25, inhibits growth of Ehrlich ascites tumor cells. FEES Lett., 309, 297-302 (1992).
18. KOPF-MAIER, P. and MUHLHAUSEN, S.K., Changes in the cytoskeleton pattern of tumor cells by cisplatin in vitro. Chem. -Biol. Interact., 82, 95-316 (1992).
19. LANDRY, J., LAMBERT, H., ZHOU, M., LAVOIE, J.N., HICKEY, E., WEBER, L.A. and ANDERSON, C.W., Human HSP27 is phosphorylated at serines 78 and 82 by heat shock and mitogen-activated kinases that recognize the same amino-acid motif as S6 kinase II. J. biol. Chem., 257, 794-803 (1992).
20. LAVOIE, J.N., LAMBERT, H., HICKEY, E., WEBER, L.A. and LANDRY, J., Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat-shock protein 27. Mol. cell. Biol., 15, 505-516 (1995).
21. LI, G.C., Heat-shock proteins: role in thermotolerance, drug resistance, and relationship to DNA topoisomerases. NCI Monogr., 4, 99-103 (1987).
22. LI, G.C. and HAHN, G.M., Ethanol-induced tolerance to heat and to adriamycin. Nature (Lond.), 274, 699-701 (1978).
23. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. and RANDALL, R.J., Protein measurement with the Folin phenol reagent. J. biol. chem., 193, 265-276 (1951).
24. MILER, C.A., COHEN, M.D. and COSTA, M., Complexing of actin and other nuclear proteins to DNA by cis-diamminedichloroplatinum(II) and chromium compounds. Carcinogenesis, 12, 269-276 (1991).
25. MIRON, T., VANCOMPERNOLLE, K., VANDEKERCKHOVE, J., WILCHEK, M. and GEIGER, B., A 25 kD inhibitor of actin polymerization is a low-molecular-mass heat-shock protein. J. Cell Biol., 114, 255-261 (1991).
26. MORIMOTO, R. I., TISSIERES, A. and GEORGOPOULOS, C., The stress response, function of the proteins and perspectives, In: R.I. Morimoto, A. Tissieres, C. Georgopoulos (eds.), Stress proteins in biology and medicine, pp. 1-36, CSH Press, Cold Spring Harbor, NY (1990).
27. NAKATA. B., BARTON, R.M., ROBBINS, K.T., HOWELL, S.B. and LOS, O., Association between HSP60 mRNA levels and cisplatin resistance in human head and neck cancer cell lines. Int. J. Oncol., 5, 1425-1432 (1994).
28. OESTERREICH, S., SCHUNCK, H., BENNDORF, R. and BIELKA, H., Cisplatin induces the small heat-shock protein hsp25 and thermotolerance in Ehrlich ascites tumor cells. Biochem. biophys. Res. Comm., 180, 243-248 (1991).
29. OESTERREICH, S., WENG, C.-N., QUI, M., HILSENBECK, S.G., OSBORN, C.K. and FUQUA, S.A.W., The small heat-shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res., 53, 4443-4448 (1993).
30. O'FARREL, P.H., High resolution two-dimensional electrophoresis of proteins. J. biol. Chem., 205, 4007-4021 (1975).
31. SARK, M.W.J., TIMMER-BOSSCHA, H., MEIJER, C., UGES, D.R.A., SLUITER, W.J., PETERS, W.H.M., MULDER, N.H. and DE VRIES, E.G.E., Cellular basis for differential sensitivity to cisplatin in human germ-cell tumour and colon carcinoma cell lines. Brit. J. Cancer, 71, 684-690 (1995).
32. SEYMOUR, L., BEZWODA, W.R. and MEYER, K., Tumor factors predicting for prognosis in metastatic breast cancer: the presence of p24 predicts for response to treatment and duration of survival, Cancer, 66, 2390-2394 (1990).
33. SPECTOR, N.L., HARDY, L., RYAN, C., MILLER, W.H., HUMES, J.L., NADLER, L.M. and LUEDKE, E., 28-kDa mammalian heat shock protein, a novel substrate of a growth-regulatory protease involved in differentiation of human leukemia cells. J. biol. Chem., 270, 1003-1006 (1995).
34. TÊTU, B., BRISSON, J., LANDRY, J. and HUOT, J., Prognostic significance of heat-shock protein-27 in node-positive breast carcinoma: an immunohistochemical study. Breast Cancer Res. Treat., 36, 93-97 (1995).
35. TÊTU, B., LACASSE, B., BOUCHARD, H.-L., LAGACE, R., HUOT, J. and LANDRY, J., Prognostic influence of HSP-27 expression in malignant fibrous histiocytoma: a clinicopathological and immunohistochemical study. Cancer Res., 52, 2325-2328 (1992).
36. THOR, A., BENZ, C., MOORE, D., GOLDMAN, E., EDGERTON, S., LANDRY, L., SCHWARTZ, L., MAYALL, B., HICKEY, E. and WEBER, L.A., Stress-response protein (srp-27) determination in primary human breast carcinomas: clinical, histological, and prognostic correlations. J. nat. Cancer Inst., 83, 170-178 (1991).
37. TIMMER-BOSSCHA, H., TIMMER, A., MEIJER, C., DE VRIES, E.G.E., DE JONG, B., OOSTERHUIS, J.W. and MULDER, N.H., Cis-diamminedichloroplatinum(II) resistance in vitro and in vivo in human embryonal carcinoma cells. Cancer Res., 53, 5707-5713 (1993).